| |
|
|
|
|
|
||||
|
|
|
|
|
|||||||
|
CEDAX® (ceftibuten) CEDAX® is an oral 3rd generation cephalosporin antibiotic that is approved in the United States for the treatment of: • Mild to moderate chronic cough (acute
bacterial exacerbations of chronic bronchitis) CEDAX® is available in 400 mg capsules and 90 mg/5 mL cherry-flavored oral suspension. Capsules are supplied in either a 20-count bottle or an oral suspension supplied in 60 mL, 90 mL and 120 mL bottles. For CEDAX® prescribing information, click here: US prescribing information. For the CEDAX® Material Safety Data Sheet, click here: Safety Data Sheet. Disclaimer: Product information on this page is intended for US residents only. In addition, the content contained here is provided for information purposes only and is not inteded to replace discussions with a physician. Decisions regarding patient care must be made together with a physician. CLICK HERE TO VISIT CEDAX WEBSITE
|
||||||||
|
|
|||||||
